{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:34:45Z","timestamp":1794864885764,"version":"4.9.1"},"reference-count":122,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2020,3,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Beh\u00e7et\u2019s Disease (BD, OMIM 109650) is a chronic relapsing inflammatory disease of unknown etiology with unpredictable exacerbations and remissions. First described in 1937 by the Turkish dermatologist HulusiBeh\u00e7et, as a trisympton complex (oral and genital ulcers and uveitis), it is now recognized as a multisystemic disease. The syndrome can manifest in diverse ways and can involve nearly every organ system. Several studies have implicated T cells and monocytes in the pathogenesis of BD especially when these cells are stimulated by heat shock proteins and streptococcal antigen. This article presents a review of the relevant published literature about the immunopathogenesis of BD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result:<\/jats:title><jats:p>The authors used MeSH terms \u201cBeh\u00e7et\u2019s disease\u201d with \u201cpathophysiology,\u201d \u201cpathogenesis,\u201d \u201cgenetic\u201d, \u201cepigenetic\u201d, \u201cimmunogenetic\u201d or \u201cimmune response\u201d to search the PubMed database. All the relevant studies identified were included.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573397115666190415142426","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T15:31:28Z","timestamp":1555428688000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunopathogenesis of Beh\u00e7et Disease"],"prefix":"10.2174","volume":"16","author":[{"given":"Israel Ga\u00f1\u00e1n","family":"Nieto","sequence":"first","affiliation":[{"name":"Department of Immunology. Hospital Universitario Ramon y Cajal, Ctra. Colmenar Viejo, Km 9,100. C.P. 28034. Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis Casta\u00f1er","family":"Alabau","sequence":"additional","affiliation":[{"name":"Department of Immunology. Hospital Universitario Ramon y Cajal, Ctra. Colmenar Viejo, Km 9,100. C.P. 28034. Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1152","volume":"105","author":"Beh\u00e7et H.","year":"1937","unstructured":"Beh\u00e7et H.; \u00dcberrezidivierendeaphth\u00f6se, durchein Virus verursachteGeschw\u00fcre am Mund, am Auge und an den Genitalien. Dermatol Monatsschr 1937,105,1152-1157","journal-title":"Dermatol Monatsschr"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00296-006-0281-6","volume":"27","author":"Pay S.","year":"2007","unstructured":"Pay S.; Sim\u015fek I.; Erdem H.; Din\u00e7 A.; Immunopathogenesis of Beh\u00e7et\u2019s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007,27(5),417-424","journal-title":"Rheumatol Int"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","volume":"27","author":"Kulaber A.","year":"2007","unstructured":"Kulaber A.; Tugal-Tutkun I.; Yent\u00fcr S.P.; Pro-inflammatory cellular immune response in Beh\u00e7et\u2019s disease. Rheumatol Int 2007,27(12),1113-1118","journal-title":"Rheumatol Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","volume":"72","author":"Dalvi S.R.","year":"2012","unstructured":"Dalvi S.R.; Yildirim R.; Yazici Y.; Behcet\u2019s Syndrome. Drugs 2012,72(17),2223-2241","journal-title":"Drugs"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","volume":"9","author":"Mendoza-Pinto C.","year":"2010","unstructured":"Mendoza-Pinto C.; Garc\u00eda-Carrasco M.; Jim\u00e9nez-Hern\u00e1ndez M.; Etiopathogenesis of Behcet\u2019s disease. Autoimmun Rev 2010,9(4),241-245","journal-title":"Autoimmun Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","volume":"4","author":"Suzuki Kurokawa M.","year":"2004","unstructured":"Suzuki Kurokawa M.; Suzuki N.; Behcet\u2019s disease. Clin Exp Med 2004,4(1),10-20","journal-title":"Clin Exp Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0198-8859(00)00249-4","volume":"62","author":"Choukri F.","year":"2001","unstructured":"Choukri F.; Chakib A.; Himmich H.; H\u00fce S.; Caillat-Zucman S.; HLA-B*51 and B*15 alleles confer predisposition to Beh\u00e7et\u2019s disease in Moroccan patients. Hum Immunol 2001,62(2),180-185","journal-title":"Hum Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09273948.2015.1136422","volume":"25","author":"Horie Y.","year":"2017","unstructured":"Horie Y.; Meguro A.; Ohta T.; HLAB51 Carriers are susceptible to ocular symptoms of Beh\u00e7et\u2019s Disease and the association between the two becomes stronger towards the East along the Silk Road: a literature survey. Ocul Immunol Inflamm 2017,25(1),37-40","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"Pineton de Chambrun M.","year":"2012","unstructured":"Pineton de Chambrun M.; Wechsler B.; Geri G.; Cacoub P.; Saadoun D.; New insights into the pathogenesis of Beh\u00e7et\u2019s disease. Autoimmun Rev 2012,11(10),687-698","journal-title":"Autoimmun Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"Ombrello M.J.","year":"2014","unstructured":"Ombrello M.J.; Kirino Y.; de Bakker P.I.; G\u00fcl A.; Kastner D.L.; Remmers E.F.; Beh\u00e7et disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci USA 2014,111(24),8867-8872","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161305","volume":"11","author":"Ortiz-Fern\u00e1ndez L.","year":"2016","unstructured":"Ortiz-Fern\u00e1ndez L.; Carmona F.D.; Montes-Cano M.A.; Genetic analysis with the immunochip platform in beh\u00e7et disease. identification of residues associated in the HLA class I region and new susceptibility loci. PLoS One 2016,11(8)","journal-title":"PLoS One"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Kirino Y.","year":"2013","unstructured":"Kirino Y.; Bertsias G.; Ishigatsubo Y.; Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013,45(2),202-207","journal-title":"Nat Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"19890","DOI":"10.1073\/pnas.1309781110","volume":"110","author":"Zervoudi E.","year":"2013","unstructured":"Zervoudi E.; Saridakis E.; Birtley J.R.; Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses. Proc Natl Acad Sci USA 2013,110(49),19890-19895","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s002510050656","volume":"49","author":"Wallace G.R.","year":"1999","unstructured":"Wallace G.R.; Verity D.H.; Delamaine L.; Association with MICA alleles with Behcet\u2019s disease. Immunogenetics 1999,49,613-617","journal-title":"Immunogenetics"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0165-5728(02)00208-4","volume":"130","author":"Nashida T.","year":"2002","unstructured":"Nashida T.; Hiruyama K.; Nakaruma S.; Proliferative response of CD8+ (gamma) (delta) T cells recovered from eyes of patients with Behcet\u2019s disease recognize prenyl pyrophosphate antigens. J Neuroimmunol 2002,130,46-54","journal-title":"J Neuroimmunol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1076\/ocii.6.2.81.4054","volume":"6","author":"Verity D.H.","year":"1998","unstructured":"Verity D.H.; Wallace G.R.; Seed P.T.; Soluble adhesion molecules in Beh\u00e7et\u2019s disease. Ocul Immunol Inflamm 1998,6(2),81-92","journal-title":"Ocul Immunol Inflamm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/BOR.0b013e3282f154d1","volume":"20","author":"Krause I.","year":"2008","unstructured":"Krause I.; Weinberger A.; Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 2008,20(1),82-87","journal-title":"Curr Opin Rheumatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/gene.2016.36","volume":"17","author":"Erer B.","year":"2016","unstructured":"Erer B.; Takeuchi M.; Ustek D.; Evaluation of KIR3DL1\/KIR3DS1 polymorphism in Beh\u00e7et\u2019s disease. Genes Immun 2016,17(7),396-399","journal-title":"Genes Immun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/2040622314523062","volume":"5","author":"Saleh Z.","year":"2014","unstructured":"Saleh Z.; Arayssi T.; Update on the therapy of Beh\u00e7et disease. Ther Adv Chronic Dis 2014,5(3),112-134","journal-title":"Ther Adv Chronic Dis"},{"key":"ref=20","first-page":"S6","volume":"19","author":"G\u00fcl A.","year":"2001","unstructured":"G\u00fcl A.; Beh\u00e7et\u2019s disease: an update on the pathogenesis. Clin Exp Rheumatol 2001,19(5)(Suppl. 24),S6-S12","journal-title":"Clin Exp Rheumatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.3786","volume":"49","author":"Takeuchi M.","year":"2017","unstructured":"Takeuchi M.; Mizuki N.; Meguro A.; Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et\u2019s disease susceptibility. Nat Genet 2017,49(3),438-443","journal-title":"Nat Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.humimm.2016.09.006","volume":"77","author":"Qin X.","year":"2016","unstructured":"Qin X.; Xu J.; Wu Z.; Association study of rs924080 and rs11209032 polymorphisms of IL23R-IL12RB2 in a Northern Chinese Han population with Behcet\u2019s disease. Hum Immunol 2016,77(12),1284-1290","journal-title":"Hum Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147350","volume":"11","author":"Chen F.","year":"2016","unstructured":"Chen F.; Xu L.; Zhao T.; Xiao X.; Pan Y.; Hou S.; Genetic variation in the REL gene increases risk of Beh\u00e7et\u2019s disease in a Chinese Han Population but that of PRKCQ does not. PLoS One 2016,11(1)","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00393-015-0036-4","volume":"75","author":"Xu Y.","year":"2016","unstructured":"Xu Y.; Zhou K.; Yang Z.; Association of cytokine gene polymorphisms (IL6, IL12B, IL18) with Behcet\u2019s disease: A meta-analysis. Z Rheumatol 2016,75(9),932-938","journal-title":"Z Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","volume":"42","author":"Karasneh J.","year":"2003","unstructured":"Karasneh J.; Hajeer A.H.; Barrett J.; Ollier W.E.; Thornhill M.; Gul A.; Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet\u2019s disease. Rheumatology (Oxford) 2003,42(7),860-864","journal-title":"Rheumatology (Oxford)"},{"key":"ref=26","first-page":"S232","volume":"9","author":"Boiardi L.","year":"2004","unstructured":"Boiardi L.; Salvarni C.; Casali B.; Single-nucleotide polymorphism located at position-607 of IL-18 gene promotor region in Beh\u00e7et\u2019s disease. Arthritis Rheum 2004,9(Suppl.),S232","journal-title":"Arthritis Rheum"},{"key":"ref=27","first-page":"S35","volume":"21","author":"Atagunduz P.","year":"2003","unstructured":"Atagunduz P.; Ergun T.; Direskeneli H.; MEFV mutations are increased in Beh\u00e7et\u2019s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003,21(4)(Suppl. 30),S35-S37","journal-title":"Clin Exp Rheumatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clindermatol.2017.06.004","volume":"35","author":"Bulur I.","year":"2017","unstructured":"Bulur I.; Onder M.; Beh\u00e7et disease: New aspects. Clin Dermatol 2017,35(5),421-434","journal-title":"Clin Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"Sakane T.","year":"1999","unstructured":"Sakane T.; Takeno M.; Suzuki N.; Inaba G.; Beh\u00e7et\u2019s disease. N Engl J Med 1999,341(17),1284-1291","journal-title":"N Engl J Med"},{"key":"ref=30","first-page":"S27","volume":"25","author":"Mumcu G.","year":"2007","unstructured":"Mumcu G.; Inanc N.; Yavuz S.; Direskeneli H.; The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2007,25(4)(Suppl. 45),S27-S33","journal-title":"Clin Exp Rheumatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/bjd.12128","volume":"168","author":"Cho S.B.","year":"2013","unstructured":"Cho S.B.; Zheng Z.; Ahn K.J.; Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2\/B1 in patients with Beh\u00e7et disease. Br J Dermatol 2013,168(5),977-983","journal-title":"Br J Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00430-002-0167-5","volume":"192","author":"Zouboulis C.C.","year":"2003","unstructured":"Zouboulis C.C.; May T.; Pathogenesis of Adamantiades-Beh\u00e7et\u2019s disease. Med Microbiol Immunol (Berl) 2003,192(3),149-155","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/ar2695","volume":"11","author":"Fei Y.","year":"2009","unstructured":"Fei Y.; Webb R.; Cobb B.L.; Direskeneli H.; Saruhan-Direskeneli G.; Sawalha A.H.; Identification of novel genetic susceptibility loci for Beh\u00e7et\u2019s disease using a genome-wide association study. Arthritis Res Ther 2009,11(3),R66","journal-title":"Arthritis Res Ther"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1099\/00222615-34-1-39","volume":"34","author":"Studd M.","year":"1991","unstructured":"Studd M.; McCance D.J.; Lehner T.; Detection of HSV-1 DNA in patients with Beh\u00e7et\u2019s syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol 1991,34(1),39-43","journal-title":"J Med Microbiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1309\/GCTH-0060-55K8-XCTT","volume":"116","author":"Demirkesen C.","year":"2001","unstructured":"Demirkesen C.; T\u00fcz\u00fcner N.; Mat C.; Clinicopathologic evaluation of nodular cutaneous lesions of Beh\u00e7et syndrome. Am J Clin Pathol 2001,116(3),341-346","journal-title":"Am J Clin Pathol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/art.1780391216","volume":"39","author":"Calg\u00fcneri M.","year":"1996","unstructured":"Calg\u00fcneri M.; Kiraz S.; Ertenli I.; Benekli M.; Karaarslan Y.; Celik I.; The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Beh\u00e7et\u2019s disease. A randomized clinical trial. Arthritis Rheum 1996,39(12),2062-2065","journal-title":"Arthritis Rheum"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000246336","volume":"192","author":"Calg\u00fcneri M.","year":"1996","unstructured":"Calg\u00fcneri M.; Ertenli I.; Kiraz S.; Erman M.; Celik I.; Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Beh\u00e7et\u2019s disease. Dermatology (Basel) 1996,192(2),125-128","journal-title":"Dermatology (Basel)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"Yurdakul S.","year":"2008","unstructured":"Yurdakul S.; Yazici H.; Beh\u00e7et\u2019s syndrome. Best Pract Res Clin Rheumatol 2008,22(5),793-809","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","volume":"105","author":"Kiraz S.","year":"2002","unstructured":"Kiraz S.; Ertenli I.; Ozt\u00fcrk M.A.; Haznedaro\u011flu I.C.; Celik I.; Calg\u00fcneri M.; Pathological haemostasis and \u201cprothrombotic state\u201d in Beh\u00e7et\u2019s disease. Thromb Res 2002,105(2),125-133","journal-title":"Thromb Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","volume":"133","author":"Becatti M.","year":"2016","unstructured":"Becatti M.; Emmi G.; Silvestri E.; Neutrophil activation promotes fibrinogen oxidation and thrombus formation in beh\u00e7et disease. Circulation 2016,133(3),302-311","journal-title":"Circulation"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nrrheum.2009.81","volume":"5","author":"Westerweel P.E.","year":"2009","unstructured":"Westerweel P.E.; Verhaar M.C.; Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol 2009,5(6),332-340","journal-title":"Nat Rev Rheumatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1164\/rccm.200907-1135OC","volume":"181","author":"Miniati M.","year":"2010","unstructured":"Miniati M.; Fiorillo C.; Becatti M.; Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. Am J Respir Crit Care Med 2010,181(9),992-996","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","volume":"34","author":"Becatti M.","year":"2014","unstructured":"Becatti M.; Marcucci R.; Bruschi G.; Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arterioscler Thromb Vasc Biol 2014,34(7),1355-1361","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0891-5849(95)93872-4","volume":"18","author":"Shacter E.","year":"1995","unstructured":"Shacter E.; Williams J.A.; Levine R.L.; Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995,18(4),815-821","journal-title":"Free Radic Biol Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-0038-1650618","volume":"76","author":"Fatah K.","year":"1996","unstructured":"Fatah K.; Silveira A.; Tornvall P.; Karpe F.; Blomb\u00e4ck M.; Hamsten A.; Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996,76(4),535-540","journal-title":"Thromb Haemost"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-3495(92)81594-1","volume":"63","author":"Weisel J.W.","year":"1992","unstructured":"Weisel J.W.; Nagaswami C.; Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992,63(1),111-128","journal-title":"Biophys J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2133.1989.tb08213.x","volume":"121","author":"Lotti T.","year":"1989","unstructured":"Lotti T.; Matucci-Cerinic M.; Cutaneous fibrinolytic potential, tPA dependent, is reduced in Beh\u00e7et\u2019s disease. Br J Dermatol 1989,121(6),713-716","journal-title":"Br J Dermatol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.icu.0000247411.59213.bb","volume":"17","author":"Okada A.A.","year":"2006","unstructured":"Okada A.A.; Beh\u00e7et\u2019s disease: general concepts and recent advances. Curr Opin Ophthalmol 2006,17(6),551-556","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","volume":"70","author":"Balta I.","year":"2014","unstructured":"Balta I.; Balta S.; Koryurek O.M.; Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease. J Am Acad Dermatol 2014,70(2),291-296","journal-title":"J Am Acad Dermatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jbspin.2014.06.007","volume":"82","author":"Capkin E.","year":"2015","unstructured":"Capkin E.; Karkucak M.; Kola M.; Karaca A.; Aydin Capkin A.; Caner Karahan S.; Ischemia-modified albumin (IMA): a novel marker of vascular involvement in Beh\u00e7et\u2019s disease? Joint Bone Spine 2015,82(1),68-69","journal-title":"Joint Bone Spine"},{"key":"ref=51","first-page":"S30","volume":"20","author":"Korkmaz C.","year":"2002","unstructured":"Korkmaz C.; Bozan B.; Kosar M.; Sahin F.; G\u00fclbas Z.; Is there an association of plasma homocysteine levels with vascular involvement in patients with Beh\u00e7et\u2019s syndrome? Clin Exp Rheumatol 2002,20(4)(Suppl. 26),S30-S34","journal-title":"Clin Exp Rheumatol"},{"key":"ref=52","first-page":"S138","volume":"26","author":"Yazici H.","year":"2008","unstructured":"Yazici H.; Esen F.; Mortality in Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 2008,26(5)(Suppl. 51),S138-S140","journal-title":"Clin Exp Rheumatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10067-004-0982-8","volume":"24","author":"Sari R.A.","year":"2005","unstructured":"Sari R.A.; Kiziltunc A.; Taysy S.; Levels of soluble E-selectin in patients with active Behcet\u2019s disease. Clin Rheumatol 2005,24(1),55-59","journal-title":"Clin Rheumatol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2133.2002.04703.x","volume":"147","author":"Evereklioglu C.","year":"2002","unstructured":"Evereklioglu C.; Inal\u00f6z H.S.; Kirtak N.; Serum leptin concentration is increased in patients with Beh\u00e7et\u2019s syndrome and is correlated with disease activity. Br J Dermatol 2002,147(2),331-336","journal-title":"Br J Dermatol"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2017.1284449","volume":"6","author":"Kahraman T.","year":"2017","unstructured":"Kahraman T.; Gucluler G.; Simsek I.; Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Beh\u00e7et\u2019s disease severity. J Extracell Vesicles 2017,6(1)","journal-title":"J Extracell Vesicles"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s00380-015-0686-9","volume":"31","author":"Bassyouni I.H.","year":"2016","unstructured":"Bassyouni I.H.; Sharaf M.; Wali I.E.; Mansour H.M.; Clinical significance of Angiopoietin-1 in Behcet\u2019s disease patients with vascular involvement. Heart Vessels 2016,31(6),918-924","journal-title":"Heart Vessels"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.autrev.2006.08.008","volume":"6","author":"Ling E.","year":"2007","unstructured":"Ling E.; Shubinsky G.; Press J.; Increased proportion of CD3+CD4-CD8- double-negative T cells in peripheral blood of children with Behcet\u2019s disease. Autoimmun Rev 2007,6(4),237-240","journal-title":"Autoimmun Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","volume":"60","author":"Zierhut M.","year":"2003","unstructured":"Zierhut M.; Mizuki N.; Ohno S.; Immunology and functional genomics of Beh\u00e7et\u2019s disease. Cell Mol Life Sci 2003,60(9),1903-1922","journal-title":"Cell Mol Life Sci"},{"key":"ref=59","first-page":"S19","volume":"19","author":"Eksioglu-Demiralp E.","year":"2001","unstructured":"Eksioglu-Demiralp E.; Direskeneli H.; Kibaroglu A.; Yavuz S.; Ergun T.; Akoglu T.; Neutrophil activation in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2001,19(5)(Suppl. 24),S19-S24","journal-title":"Clin Exp Rheumatol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0065-2776(08)60791-9","volume":"73","author":"Cassatella M.A.","year":"1999","unstructured":"Cassatella M.A.; Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999,73,369-509","journal-title":"Adv Immunol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1189\/jlb.69.5.698","volume":"69","author":"Yamashiro S.","year":"2001","unstructured":"Yamashiro S.; Kamohara H.; Wang J.M.; Yang D.; Gong W.H.; Yoshimura T.; Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 2001,69(5),698-704","journal-title":"J Leukoc Biol"},{"key":"ref=62","volume":"56","author":"Sakane T.","unstructured":"Sakane T.; Suzuki N.; Takeno M.; Innate and acquired immunity in Behc\u00b8et\u2019s disease. 8th International conference on Beh\u00e7et\u2019s disease ,56","journal-title":"8th International conference on Beh\u00e7et\u2019s disease"},{"key":"ref=63","volume":"57","author":"Takeno M.","unstructured":"Takeno M.; Shimoyama Y.; Suzuki N.; Sakane T.; Prolonged survival of auto-primed neutrophils from patients with Beh\u00e7et\u2019s disease. 8th International conference on Beh\u00e7et\u2019s disease ,57","journal-title":"8th International conference on Beh\u00e7et\u2019s disease"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.4049\/jimmunol.165.10.5814","volume":"165","author":"Witowski J.","year":"2000","unstructured":"Witowski J.; Pawlaczyk K.; Breborowicz A.; IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000,165(10),5814-5821","journal-title":"J Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.1990.tb08095.x","volume":"79","author":"Niwa Y.","year":"1990","unstructured":"Niwa Y.; Mizushima Y.; Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Beh\u00e7et\u2019s disease. Clin Exp Immunol 1990,79(3),353-360","journal-title":"Clin Exp Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.4049\/jimmunol.167.5.2879","volume":"167","author":"Leung B.P.","year":"2001","unstructured":"Leung B.P.; Culshaw S.; Gracie J.A.; A role for IL-18 in neutrophil activation. J Immunol 2001,167(5),2879-2886","journal-title":"J Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2230.2004.01488.x","volume":"29","author":"Gunduz K.","year":"2004","unstructured":"Gunduz K.; Ozturk G.; Sozmen E.Y.; Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Beh\u00e7et disease and recurrent aphthous stomatitis. Clin Exp Dermatol 2004,29(2),176-179","journal-title":"Clin Exp Dermatol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"Yazici C.","year":"2004","unstructured":"Yazici C.; K\u00f6se K.; Cali\u015f M.; DemIr M.; Kirnap M.; Ate\u015f F.; Increased advanced oxidation protein products in Beh\u00e7et\u2019s disease: a new activity marker? Br J Dermatol 2004,151(1),105-111","journal-title":"Br J Dermatol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1468-3083.2003.t01-1-00574.x","volume":"17","author":"Sancak B.","year":"2003","unstructured":"Sancak B.; Onder M.; Oztas M.O.; Bukan N.; G\u00fcrer M.A.; Nitric oxide levels in Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol 2003,17(1),7-9","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/jcp.37.6.616","volume":"37","author":"Kohn S.","year":"1984","unstructured":"Kohn S.; Haim S.; Gilhar A.; Friedman-Birnbaum R.; Nir I.; Epidermal Langerhans\u2019 cells in Beh\u00e7et\u2019s disease. J Clin Pathol 1984,37(6),616-619","journal-title":"J Clin Pathol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1440-0960.1988.tb00398.x","volume":"29","author":"K\u00fcrk\u00e7\u00fco\u011flu N.","year":"1988","unstructured":"K\u00fcrk\u00e7\u00fco\u011flu N.; \u00c7akar N.; Epidermal Langerhans cells in patients with Beh\u00e7et\u2019s syndrome. Australas J Dermatol 1988,29(3),185-187","journal-title":"Australas J Dermatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000250351","volume":"161","author":"Saito T.","year":"1980","unstructured":"Saito T.; Honma T.; Saigo K.; Epidermal Langerhans\u2019 cells after the prick test for Beh\u00e7et\u2019s disease. Dermatologica 1980,161(3),152-156","journal-title":"Dermatologica"},{"key":"ref=73","first-page":"1544","volume":"20","author":"Mege J.L.","year":"1993","unstructured":"Mege J.L.; Dilsen N.; Sanguedolce V.; Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993,20(9),1544-1549","journal-title":"J Rheumatol"},{"key":"ref=74","first-page":"S20","volume":"23","author":"K\u00f6tter I.","year":"2005","unstructured":"K\u00f6tter I.; Koch S.; Vonthein R.; Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Beh\u00e7et\u2019s disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 2005,23(4)(Suppl. 38),S20-S26","journal-title":"Clin Exp Rheumatol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"Theofilopoulos A.N.","year":"2005","unstructured":"Theofilopoulos A.N.; Baccala R.; Beutler B.; Kono D.H.; Type I interferons (alpha\/beta) in immunity and autoimmunity. Annu Rev Immunol 2005,23,307-336","journal-title":"Annu Rev Immunol"},{"key":"ref=76","author":"Pay S.","year":"2006","unstructured":"Pay S.; Simsek I.; Erdem H.; Quantitative and functional analysis of dendritic cell subsets in Beh\u00e7et\u2019s disease: does functional abnormality in plasmacytoiddendtritic cell contribute to Th1 polarization? 12th International conference on Beh\u00e7et\u2019s disease 2006","journal-title":"12th International conference on Beh\u00e7et\u2019s disease"},{"key":"ref=77","first-page":"329","volume":"25","author":"Raziuddin S.","year":"1998","unstructured":"Raziuddin S.; al-Dalaan A.; Bahabri S.; Siraj A.K.; al-Sedairy S.; Divergent cytokine production profile in Beh\u00e7et\u2019s disease. Altered Th1\/Th2 cell cytokine pattern. J Rheumatol 1998,25(2),329-333","journal-title":"J Rheumatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"Ben Ahmed M.","year":"2004","unstructured":"Ben Ahmed M.; Houman H.; Miled M.; Dellagi K.; Louzir H.; Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et\u2019s disease. Arthritis Rheum 2004,50(7),2291-2295","journal-title":"Arthritis Rheum"},{"key":"ref=79","first-page":"S8","volume":"21","author":"Hamzaoui A.","year":"2003","unstructured":"Hamzaoui A.; Ghra\u00efri H.; Ammar J.; Zekri S.; Guemira F.; Hamzaoui K.; IL-18 mRNA expression and IFN-\u03b3 induction in bronchoalveolar lavage from Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2003,21(4)(Suppl. 30),S8-S14","journal-title":"Clin Exp Rheumatol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08820139.2017.1288240","volume":"46","author":"Cosan F.","year":"2017","unstructured":"Cosan F.; Aktas Cetin E.; Akdeniz N.; Emrence Z.; Cefle A.; Deniz G.; Natural killer cell subsets and their functional activity in Beh\u00e7et\u2019s disease. Immunol Invest 2017,46(4),419-432","journal-title":"Immunol Invest"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/cei.12939","volume":"188","author":"Hasan M.S.","year":"2017","unstructured":"Hasan M.S.; Ryan P.L.; Bergmeier L.A.; Fortune F.; Circulating NK cells and their subsets in Beh\u00e7et\u2019s disease. Clin Exp Immunol 2017,188(2),311-322","journal-title":"Clin Exp Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/rheumatology\/keh195","volume":"43","author":"Koarada S.","year":"2004","unstructured":"Koarada S.; Haruta Y.; Tada Y.; Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet\u2019s disease. Rheumatology (Oxford) 2004,43(7),843-851","journal-title":"Rheumatology (Oxford)"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"Hamzaoui K.","year":"2002","unstructured":"Hamzaoui K.; Hamzaoui A.; Guemira F.; Bessioud M.; Hamza M.; Ayed K.; Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 2002,31(4),205-210","journal-title":"Scand J Rheumatol"},{"key":"ref=84","first-page":"3480","volume":"41","author":"de Smet M.D.","year":"2000","unstructured":"de Smet M.D.; Dayan M.; Prospective determination of T-cell responses to S-antigen in Beh\u00e7et\u2019s disease patients and controls. Invest Ophthalmol Vis Sci 2000,41(11),3480-3484","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","volume":"26","author":"Musabak U.","year":"2006","unstructured":"Musabak U.; Pay S.; Erdem H.; Serum interleukin-18 levels in patients with Beh\u00e7et\u2019s disease. Is its expression associated with disease activity or clinical presentations? Rheumatol Int 2006,26(6),545-550","journal-title":"Rheumatol Int"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","volume":"128","author":"Geri G.","year":"2011","unstructured":"Geri G.; Terrier B.; Rosenzwajg M.; Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et disease. J Allergy Clin Immunol 2011,128(3),655-664","journal-title":"J Allergy Clin Immunol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"Chi W.","year":"2008","unstructured":"Chi W.; Zhu X.; Yang P.; Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis. Invest Ophthalmol Vis Sci 2008,49(7),3058-3064","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.lfs.2012.03.017","volume":"90","author":"Kim E.S.","year":"2012","unstructured":"Kim E.S.; Kim S.W.; Moon C.M.; Interactions between IL17A, IL23R and STAT4 polymorphisms confer susceptibility to intestinal Behcet\u2019s disease in Korean population. Life Sci 2012,90(19-20),740-746","journal-title":"Life Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","volume":"168","author":"Zarember K.A.","year":"2002","unstructured":"Zarember K.A.; Godowski P.J.; Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products and cytokines. J Immunol 2002,168(2),554-561","journal-title":"J Immunol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","volume":"30","author":"Oztas M.O.","year":"2005","unstructured":"Oztas M.O.; Onder M.; Gurer M.A.; Bukan N.; Sancak B.; Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet\u2019s disease. Clin Exp Dermatol 2005,30(1),61-63","journal-title":"Clin Exp Dermatol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","volume":"186","author":"Gholijani N.","year":"2017","unstructured":"Gholijani N.; Ataollahi M.R.; Samiei A.; Aflaki E.; Shenavandeh S.; Kamali-Sarvestani E.; An elevated pro-inflammatory cytokines profile in Behcet\u2019s disease: A multiplex analysis. Immunol Lett 2017,186,46-51","journal-title":"Immunol Lett"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/17843286.2017.1314241","volume":"72","author":"\u00c7er\u00e7i P.","year":"2017","unstructured":"\u00c7er\u00e7i P.; Alt\u0131ner S.; \u0130nal A.; K\u00f6se K.; Keskin G.; \u00d6lmez \u00dc.; Investigating the role of IL-33 in the pathogenesis of Beh\u00e7et\u2019s Disease. Acta Clin Belg 2017,72(6),434-438","journal-title":"Acta Clin Belg"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/1756-185X.13072","volume":"21","author":"Ha Y.J.","year":"2018","unstructured":"Ha Y.J.; Park J.S.; Kang M.I.; Lee S.K.; Park Y.B.; Lee S.W.; Increased serum interleukin-32 levels in patients with Beh\u00e7et\u2019s disease. Int J Rheum Dis 2018,21(12),2167-2174","journal-title":"Int J Rheum Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10067-015-2966-2","volume":"35","author":"Shimizu J.","year":"2016","unstructured":"Shimizu J.; Takai K.; Takada E.; Possible association of proinflammatory cytokines including IL1\u03b2 and TNF\u03b1 with enhanced Th17 cell differentiation in patients with Behcet\u2019s disease. Clin Rheumatol 2016,35(7),1857-1863","journal-title":"Clin Rheumatol"},{"key":"ref=95","first-page":"S71","volume":"29","author":"Hamzaoui K.","year":"2011","unstructured":"Hamzaoui K.; Th17 cells in Beh\u00e7et\u2019s disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011,29(4)(Suppl. 67),S71-S76","journal-title":"Clin Exp Rheumatol"},{"key":"ref=96","author":"Hatemi G","unstructured":"Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V; One year in review 2017: Beh\u00e7et's syndrome ClinExpRheumatol 2017; 108 |(6 ): 3-15."},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/08820139.2017.1306865","volume":"46","author":"Deniz R.","year":"2017","unstructured":"Deniz R.; Tulunay-Virlan A.; Ture Ozdemir F.; Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet\u2019s Disease. Immunol Invest 2017,46(5),518-525","journal-title":"Immunol Invest"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/ard.60.11.996","volume":"60","author":"Direskeneli H.","year":"2001","unstructured":"Direskeneli H.; Beh\u00e7et\u2019s disease: infectious aetiology, new autoantigens and HLA-B51. Ann Rheum Dis 2001,60(11),996-1002","journal-title":"Ann Rheum Dis"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bjo.77.9.584","volume":"77","author":"Yamamoto J.H.","year":"1993","unstructured":"Yamamoto J.H.; Minami M.; Inaba G.; Masuda K.; Mochizuki M.; Cellular autoimmunity to retinal specific antigens in patients with Beh\u00e7et\u2019s disease. Br J Ophthalmol 1993,77(9),584-589","journal-title":"Br J Ophthalmol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","volume":"140","author":"Hirohata S.","year":"1992","unstructured":"Hirohata S.; Oka H.; Mizushima Y.; Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet\u2019s disease. Cell Immunol 1992,140(2),410-419","journal-title":"Cell Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-2249.1998.00572.x","volume":"112","author":"Hirohata S.","year":"1998","unstructured":"Hirohata S.; Hashimoto T.; Abnormal T cell responses to bacterial superantigens in Beh\u00e7et\u2019s disease (BD). Clin Exp Immunol 1998,112(2),317-324","journal-title":"Clin Exp Immunol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1067\/mlc.2003.1","volume":"141","author":"Bank I.","year":"2003","unstructured":"Bank I.; Duvdevani M.; Livneh A.; Expansion of gammadelta T-cells in Beh\u00e7et\u2019s disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003,141(1),33-40","journal-title":"J Lab Clin Med"},{"key":"ref=103","first-page":"826","volume":"26","author":"Ek\u015fioglu-Demiralp E.","year":"1999","unstructured":"Ek\u015fioglu-Demiralp E.; Kibaroglu A.; Direskeneli H.; Phenotypic characteristics of B cells in Beh\u00e7et\u2019s disease: increased activity in B cell subsets. J Rheumatol 1999,26(4),826-832","journal-title":"J Rheumatol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","volume":"118","author":"Freysdottir J.","year":"1999","unstructured":"Freysdottir J.; Lau S.; Fortune F.; Gammadelta T cells in Beh\u00e7et\u2019s disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999,118(3),451-457","journal-title":"Clin Exp Immunol"},{"key":"ref=105","first-page":"S87","volume":"24","author":"Monselise A.","year":"2006","unstructured":"Monselise A.; Weinberger A.; Monselise Y.; Fraser A.; Sulkes J.; Krause I.; Anti-Saccharomyces cerevisiae antibodies in Beh\u00e7et\u2019s disease--a familial study. Clin Exp Rheumatol 2006,24(5)(Suppl. 42),S87-S90","journal-title":"Clin Exp Rheumatol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","volume":"40","author":"Tokay S.","year":"2001","unstructured":"Tokay S.; Direskeneli H.; Yurdakul S.; Akoglu T.; Anticardiolipin antibodies in Beh\u00e7et\u2019s disease: a reassessment. Rheumatology (Oxford) 2001,40(2),192-195","journal-title":"Rheumatology (Oxford)"},{"key":"ref=107","first-page":"1629","volume":"84","author":"Zeng X.J.","year":"2004","unstructured":"Zeng X.J.; Zhu W.G.; Deng X.X.; Tang F.L.; Dong Y.; Anti-endothelial cell antibodies in systemic vasculitis: detection and correlation with disease activity. Zhonghua Yi Xue Za Zhi 2004,84(19),1629-1632","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00296-002-0274-z","volume":"24","author":"Aslan H.","year":"2004","unstructured":"Aslan H.; Pay S.; Gok F.; Antiannexin V autoantibody in thrombophilic Beh\u00e7et\u2019s disease. Rheumatol Int 2004,24(2),77-79","journal-title":"Rheumatol Int"},{"key":"ref=109","first-page":"S67","volume":"27","author":"Vural B.","year":"2009","unstructured":"Vural B.; Demirkan A.; Ugurel E.; Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2009,27(2)(Suppl. 53),S67-S72","journal-title":"Clin Exp Rheumatol"},{"key":"ref=110","first-page":"260","volume":"10","author":"Tunc R.","year":"2001","unstructured":"Tunc R.; Ozbakir F.; Caglayan A.; Absence of ANCA in Beh\u00e7et syndrome with large vessel involvement. Angiology 2001,10,260-262","journal-title":"Angiology"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1067\/mjd.2001.117728","volume":"45","author":"Ergun T.","year":"2001","unstructured":"Ergun T.; Ince U.; Ek\u015fio\u011flu-Demiralp E.; HSP 60 expression in mucocutaneous lesions of Beh\u00e7et\u2019s disease. J Am Acad Dermatol 2001,45(6),904-909","journal-title":"J Am Acad Dermatol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(96)90868-5","volume":"347","author":"Hasan A.","year":"1996","unstructured":"Hasan A.; Fortune F.; Wilson A.; Role of gamma delta T cells in pathogenesis and diagnosis of Behcet\u2019s disease. Lancet 1996,347(9004),789-794","journal-title":"Lancet"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.151.4.2273","volume":"151","author":"Pervin K.","year":"1993","unstructured":"Pervin K.; Childerstone A.; Shinnick T.; T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Beh\u00e7et\u2019s disease. J Immunol 1993,151(4),2273-2282","journal-title":"J Immunol"},{"key":"ref=114","first-page":"S44","volume":"21","author":"Direskeneli H.","year":"2003","unstructured":"Direskeneli H.; Saruhan-Direskeneli G.; The role of heat shock proteins in Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2003,21(4)(Suppl. 30),S44-S48","journal-title":"Clin Exp Rheumatol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10350-006-0706-z","volume":"49","author":"Choi C.H.","year":"2006","unstructured":"Choi C.H.; Kim T.I.; Kim B.C.; Anti-Saccharomyces cerevisiae antibody in intestinal Beh\u00e7et\u2019s disease patients: relation to clinical course. Dis Colon Rectum 2006,49(12),1849-1859","journal-title":"Dis Colon Rectum"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.3748\/wjg.14.7271","volume":"14","author":"Filik L.","year":"2008","unstructured":"Filik L.; Biyikoglu I.; Differentiation of Behcet\u2019s disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol 2008,14(47),7271","journal-title":"World J Gastroenterol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02208085","volume":"14","author":"Direskeneli H.","year":"1995","unstructured":"Direskeneli H.; Keser G.; D\u2019Cruz D.; Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Beh\u00e7et\u2019s disease. Clin Rheumatol 1995,14(1),55-61","journal-title":"Clin Rheumatol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/clin.1993.1059","volume":"67","author":"Ayd\u00ecntug A.O.","year":"1993","unstructured":"Ayd\u00ecntug A.O.; Tokg\u00f6z G.; D\u2019Cruz D.P.; Antibodies to endothelial cells in patients with Beh\u00e7et\u2019s disease. Clin Immunol Immunopathol 1993,67(2),157-162","journal-title":"Clin Immunol Immunopathol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.11074","volume":"48","author":"Lee K.H.","year":"2003","unstructured":"Lee K.H.; Chung H.S.; Kim H.S.; Human \u03b1-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Beh\u00e7et\u2019s disease. Arthritis Rheum 2003,48(7),2025-2035","journal-title":"Arthritis Rheum"},{"key":"ref=120","first-page":"67","volume":"35","author":"Kang S.E.","year":"2017","unstructured":"Kang S.E.; Lee S.J.; Lee J.Y.; Serum levels of IgG antibodies against alpha-enolase are increased in patients with Beh\u00e7et\u2019s disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates and C-reactive protein. Clin Exp Rheumatol 2017,35(6)(Suppl. 108),67-74","journal-title":"Clin Exp Rheumatol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/rheumatology\/kew366","volume":"56","author":"van der Houwen T.B.","year":"2017","unstructured":"van der Houwen T.B.; van Hagen P.M.; Timmermans W.M.; Chronic signs of memory B cell activation in patients with Beh\u00e7et\u2019s disease are partially restored by anti-tumour necrosis factor treatment. Rheumatology (Oxford) 2017,56(1),134-144","journal-title":"Rheumatology (Oxford)"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1346-8138.13381","volume":"43","author":"Alpsoy E.","year":"2016","unstructured":"Alpsoy E.; Beh\u00e7et\u2019s disease: A comprehensive review with a focus on epidemiology, etiology and clinical features and management of mucocutaneous lesions. J Dermatol 2016,43(6),620-632","journal-title":"J Dermatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:08:55Z","timestamp":1694808535000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171622\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397115666190415142426","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}